NEW YORK (GenomeWeb News) – Orchid Cellmark today reported a 14-percent decline in revenues amid mounting losses for the second quarter.
Total revenues for the second quarter fell to $13.6 million from $15.8 million in the year-ago period. Orchid said that the decline in revenues was largely due to lower US government paternity and forensic casework and lower overall UK forensic service revenues.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.